233 related articles for article (PubMed ID: 23315939)
1. β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.
Gesty-Palmer D; Yuan L; Martin B; Wood WH; Lee MH; Janech MG; Tsoi LC; Zheng WJ; Luttrell LM; Maudsley S
Mol Endocrinol; 2013 Feb; 27(2):296-314. PubMed ID: 23315939
[TBL] [Abstract][Full Text] [Related]
2. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
3. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
4. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation.
Gesty-Palmer D; Flannery P; Yuan L; Corsino L; Spurney R; Lefkowitz RJ; Luttrell LM
Sci Transl Med; 2009 Oct; 1(1):1ra1. PubMed ID: 20368153
[TBL] [Abstract][Full Text] [Related]
5. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
6. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
7. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
8. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
Gesty-Palmer D; Luttrell LM
Br J Pharmacol; 2011 Sep; 164(1):59-67. PubMed ID: 21506957
[TBL] [Abstract][Full Text] [Related]
9. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
[TBL] [Abstract][Full Text] [Related]
10. Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts.
Bianchi EN; Ferrari SL
Bone; 2009 Oct; 45(4):716-25. PubMed ID: 19560570
[TBL] [Abstract][Full Text] [Related]
11. Delineation of a conserved arrestin-biased signaling repertoire in vivo.
Maudsley S; Martin B; Gesty-Palmer D; Cheung H; Johnson C; Patel S; Becker KG; Wood WH; Zhang Y; Lehrmann E; Luttrell LM
Mol Pharmacol; 2015 Apr; 87(4):706-17. PubMed ID: 25637603
[TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL
J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183
[TBL] [Abstract][Full Text] [Related]
13. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
[TBL] [Abstract][Full Text] [Related]
14. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
[TBL] [Abstract][Full Text] [Related]
15. Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.
Nakaya M; Chikura S; Watari K; Mizuno N; Mochinaga K; Mangmool S; Koyanagi S; Ohdo S; Sato Y; Ide T; Nishida M; Kurose H
J Biol Chem; 2012 Oct; 287(42):35669-35677. PubMed ID: 22888001
[TBL] [Abstract][Full Text] [Related]
16. Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts.
Spurney RF
Calcif Tissue Int; 2003 Aug; 73(2):153-60. PubMed ID: 14565597
[TBL] [Abstract][Full Text] [Related]
17. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.
Maudsley S; Martin B; Janssens J; Etienne H; Jushaj A; van Gastel J; Willemsen A; Chen H; Gesty-Palmer D; Luttrell LM
Methods; 2016 Jan; 92():51-63. PubMed ID: 25986936
[TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons.
Walwyn W; Evans CJ; Hales TG
J Neurosci; 2007 May; 27(19):5092-104. PubMed ID: 17494695
[TBL] [Abstract][Full Text] [Related]
19. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
Stevenson RW; Parsons JA
J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
[TBL] [Abstract][Full Text] [Related]
20. Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2.
Whitfield JF; Morley P; Willick GE; Isaacs RJ; MacLean S; Ross V; Barbier JR; Divieti P; Bringhurst FR
J Bone Miner Res; 2000 May; 15(5):964-70. PubMed ID: 10804028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]